Extrachromosomal Amplification of Human Papillomavirus Episomes as a Mechanism of Cervical Carcinogenesis

Integration of Human Papillomaviruses (HPV) is an important mechanism of carcinogenesis but is absent in a significant fraction of HPV16+ tumors. We applied long-read whole-genome sequencing (WGS) to cervical cancer cell lines and tumors. In two HPV16+ cell lines, we identified large tandem arrays of full-length and truncated viral genomes integrated into multiple locations indicating formation as extrachromosomal DNA (HPV superspreading). An HPV16+ cell line with episomal DNA has tandem arrays of full-length, truncated, and rearranged HPV16 genomes (multimer episomes). WGS of HPV16+ cervical tumors revealed that 11/20 with only episomal HPV (EP) have intact monomer episomes. The remaining nine EP tumors have multimer and rearranged HPV genomes. Most HPV rearrangements disrupt the E1 and E2 genes, and EP tumors overexpress the E6 and E7 viral oncogenes. Tumors with both episomal and integrated HPV16 display multimer episomes and concatemers of human and viral sequences. One tumor has a recurrent deletion of an inhibitory site regulating E6 and E7 expression, and another has a recurrent duplication consistent with HPV superspreading. Therefore, HPV16 can cause cancer without integration through aberrant episomal replication, forming rearranged and multimer episomes.

[1]  Laurel L. Ball,et al.  Extrachromosomal DNA in HPV-Mediated Oropharyngeal Cancer Drives Diverse Oncogene Transcription , 2021, Clinical Cancer Research.

[2]  Howard Y. Chang,et al.  Extrachromosomal DNA is associated with oncogene amplification and poor outcome across multiple cancers , 2020, Nature Genetics.

[3]  M. Yeager,et al.  The D2 and D3 Sublineages of Human Papilloma Virus 16–Positive Cervical Cancer in Guatemala Differ in Integration Rate and Age of Diagnosis , 2020, Cancer Research.

[4]  S. Sukumar,et al.  Targeted nanopore sequencing with Cas9-guided adapter ligation , 2020, Nature Biotechnology.

[5]  Zhongming Zhao,et al.  VISDB: a manually curated database of viral integration sites in the human genome , 2019, Nucleic Acids Res..

[6]  Geo Pertea,et al.  Transcriptome assembly from long-read RNA-seq alignments with StringTie2 , 2019, Genome Biology.

[7]  P. Lambert,et al.  A Human Papillomavirus-Independent Cervical Cancer Animal Model Reveals Unconventional Mechanisms of Cervical Carcinogenesis , 2019, Cell reports.

[8]  Chase W. Nelson,et al.  The Intersection of HPV Epidemiology, Genomics and Mechanistic Studies of HPV-Mediated Carcinogenesis , 2018, Viruses.

[9]  Mirit I Aladjem,et al.  HPV integration hijacks and multimerizes a cellular enhancer to generate a viral-cellular super-enhancer that drives high viral oncogene expression , 2018, PLoS genetics.

[10]  A. Sethi,et al.  The Cancer Genomics Cloud: Collaborative, Reproducible, and Democratized-A New Paradigm in Large-Scale Computational Research. , 2017, Cancer research.

[11]  Y. Qi,et al.  Genomic characterization of human papillomavirus-positive and -negative human squamous cell cancer cell lines , 2017, Oncotarget.

[12]  L. Dinardo,et al.  Integration of Human Papillomavirus Genomes in Head and Neck Cancer: Is It Time to Consider a Paradigm Shift? , 2017, Viruses.

[13]  Drew Daniel.  Transcripts , 2017, Spaces of Intensity.

[14]  Steven J. M. Jones,et al.  Integrated genomic and molecular characterization of cervical cancer , 2017, Nature.

[15]  Nicolas Wentzensen,et al.  Carcinogenic human papillomavirus infection , 2016, Nature Reviews Disease Primers.

[16]  M. Machiela,et al.  Genomic characterization of viral integration sites in HPV‐related cancers , 2016, International journal of cancer.

[17]  M. Yeager,et al.  HPV16 Sublineage Associations With Histology-Specific Cancer Risk Using HPV Whole-Genome Sequences in 3200 Women. , 2016, Journal of the National Cancer Institute.

[18]  M. Ustav,et al.  Initial amplification of the HPV18 genome proceeds via two distinct replication mechanisms , 2015, Scientific Reports.

[19]  M. Yeager,et al.  Genome Analysis of Latin American Cervical Cancer: Frequent Activation of the PIK3CA Pathway , 2015, Clinical Cancer Research.

[20]  X. Fang,et al.  Genome-wide profiling of HPV integration in cervical cancer identifies clustered genomic hot spots and a potential microhomology-mediated integration mechanism , 2015, Nature Genetics.

[21]  S. Roychoudhury,et al.  Physical and methylation status of human papillomavirus 16 in asymptomatic cervical infections changes with malignant transformation , 2015, Journal of Clinical Pathology.

[22]  Chandra Sekhar Pedamallu,et al.  Characterization of HPV and host genome interactions in primary head and neck cancers , 2014, Proceedings of the National Academy of Sciences.

[23]  M. Boeri,et al.  YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypes , 2014, Oncotarget.

[24]  T. Ried,et al.  Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability , 2014, Genome research.

[25]  P. Chan,et al.  Virological characteristics of cervical cancers carrying pure episomal form of HPV16 genome. , 2013, Gynecologic oncology.

[26]  R. Burk,et al.  Human papillomavirus genome variants. , 2013, Virology.

[27]  M. Ustav,et al.  Recombination-Dependent Oligomerization of Human Papillomavirus Genomes upon Transient DNA Replication , 2013, Journal of Virology.

[28]  S. Wolf,et al.  Multiplex Identification of Human Papillomavirus 16 DNA Integration Sites in Cervical Carcinomas , 2013, PloS one.

[29]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration , 2012, Briefings Bioinform..

[30]  B. Faircloth,et al.  Primer3—new capabilities and interfaces , 2012, Nucleic acids research.

[31]  F. Thierry,et al.  Tumor suppressor or oncogene? A critical role of the human papillomavirus (HPV) E2 protein in cervical cancer progression. , 2011, American journal of cancer research.

[32]  Nicolas Stransky,et al.  Frequent genomic structural alterations at HPV insertion sites in cervical carcinoma , 2010, The Journal of pathology.

[33]  M. Stanley,et al.  In vitro progression of human papillomavirus 16 episome-associated cervical neoplasia displays fundamental similarities to integrant-associated carcinogenesis. , 2010, Cancer research.

[34]  Thomas H. Haugen,et al.  Upstream Regulatory Region Alterations Found in Human Papillomavirus Type 16 (HPV-16) Isolates from Cervical Carcinomas Increase Transcription, ori Function, and HPV Immortalization Capacity in Culture , 2009, Journal of Virology.

[35]  I. Runnebaum,et al.  Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts , 2008, Oncogene.

[36]  Magnus von Knebel Doeberitz,et al.  Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. , 2008, Cancer research.

[37]  C. Martin,et al.  The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines. , 2007, Oral oncology.

[38]  Mark Schiffman,et al.  The promise of global cervical-cancer prevention. , 2005, The New England journal of medicine.

[39]  S. Vinokurova,et al.  Systematic Review of Genomic Integration Sites of Human Papillomavirus Genomes in Epithelial Dysplasia and Invasive Cancer of the Female Lower Genital Tract , 2004, Cancer Research.

[40]  W. J. Kent,et al.  BLAT--the BLAST-like alignment tool. , 2002, Genome research.

[41]  J. Peto,et al.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide , 1999, The Journal of pathology.

[42]  H. Shih,et al.  Molecular analysis of episomal human papillomavirus type 16 DNA in a cervical carcinoma cell line. , 1997, Virus research.

[43]  J. Ku,et al.  Establishment and characterization of 12 uterine cervical‐carcinoma cell lines: Common sequence variation in the E7 gene of HPV‐16‐positive cell lines , 1997, International journal of cancer.

[44]  D. Galloway,et al.  Human papillomavirus type 16 E7 alleviates a proliferation block in early passage human mammary epithelial cells. , 1996, Oncogene.

[45]  P. Howley,et al.  Suppression of cellular proliferation by the papillomavirus E2 protein , 1995, Journal of virology.

[46]  P. Lambert,et al.  Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells , 1995, Journal of virology.

[47]  F. Stubenrauch,et al.  The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1. , 1994, The EMBO journal.

[48]  S. Schneider-Maunoury,et al.  Integration of papillomavirus DNA near myc genes in genital carcinomas and its consequences for proto-oncogene expression , 1991, Journal of virology.

[49]  J. G. van den Tweel,et al.  Human papillomavirus type 16 transcripts expressed from viral-cellular junctions and full-length viral copies in CaSki cells and in a cervical carcinoma. , 1991, Virology.

[50]  Arnold J. Levine,et al.  The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 , 1990, Cell.

[51]  A. Levine,et al.  Association of human papillomavirus types 16 and 18 E6 proteins with p53. , 1990, Science.

[52]  M. Wagatsuma,et al.  Analysis of integrated human papillomavirus type 16 DNA in cervical cancers: amplification of viral sequences together with cellular flanking sequences , 1990, Journal of virology.

[53]  K. Choo,et al.  Presence of catenated human papillomavirus type 16 episomes in a cervical carcinoma cell line , 1989, Journal of virology.

[54]  G. Wahl,et al.  Double minute chromosomes can be produced from precursors derived from a chromosomal deletion , 1988, Molecular and cellular biology.

[55]  M. Braun,et al.  Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines , 1987, Journal of virology.

[56]  Wolfgang Mayer,et al.  Structure and transcription of human papillomavirus sequences in cervical carcinoma cells , 1985, Nature.

[57]  Y. Ito,et al.  Studies on a New Human Cell Line (SiHa) Derived from Carcinoma of Uterus. I. Its Establishment and Morphology 1 , 1970, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.